| Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review AM Suliman, SA Bek, MS Elkhatim, AA Husain, AY Mismar, MZS Eldean, ... Cancer Immunology, Immunotherapy 70, 935-944, 2021 | 29 | 2021 |
| Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS) NE Omar, AIF Soliman, M Eshra, T Saeed, A Hamad, A Abou-Ali ESMO open 6 (6), 100315, 2021 | 26 | 2021 |
| Stigma towards health care providers taking care of COVID-19 patients: A multi-country study AJ Nashwan, GFD Valdez, ALF Sadeq, H Al-Najjar, H Elamir, M Barakat, ... Heliyon 8 (4), 2022 | 23 | 2022 |
| Perceptions and expectations of health care providers towards clinical pharmacy services in a mental health hospital in Qatar Y Eltorki, O Abdallah, N Omar, M Zolezzi Asian journal of psychiatry 42, 62-66, 2019 | 22 | 2019 |
| Diagnosis and management of hematological adverse events induced by immune checkpoint inhibitors: a systematic review NE Omar, KA El-Fass, AI Abushouk, N Elbaghdady, AEM Barakat, ... Frontiers in immunology 11, 531929, 2020 | 21 | 2020 |
| Diabetes-induced proteome changes throughout development D Johar, SM Ahmed, S El Hayek, N Al-Dewik, EI Bahbah, NH Omar, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019 | 19 | 2019 |
| Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar NE Omar, S Elazzazy, O Abdallah, AJ Nashwan, Y Eltorki, HM Afifi, ... Journal of Oncology Pharmacy Practice 26 (5), 1086-1096, 2020 | 18 | 2020 |
| Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia A Basha, MIM Ibrahim, A Hamad, P Chandra, NE Omar, MAJ Abdullah, ... PloS one 16 (8), e0255104, 2021 | 11 | 2021 |
| Outcomes of patient education practices to optimize the safe use of lithium: A literature review M Zolezzi, YH Eltorki, M Almaamoon, M Fathy, NE Omar Mental Health Clinician 8 (1), 41-48, 2018 | 10 | 2018 |
| COVID-19 vaccination in cancer patients: A review article R Mekkawi, BA Elkattan, A Shablak, M Bakr, MA Yassin, NE Omar Cancer Control 29, 10732748221106266, 2022 | 9 | 2022 |
| Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme: A case report and literature review F Ata, SFA Veettil, M Gaber, NE Omar, A Madani, HM Afifi, MM Aldardouri, ... Clinical Case Reports 9 (3), 1641, 2021 | 4 | 2021 |
| Pancytopenia and limbic encephalopathy complicating immunotherapy for clear cell endometrial cancer with Microsatellite Instability-High (MSI-H) A Kanbour, KI Rasul, S Bujassoum Albader, RJ Al Sulaiman, G Melikyan, ... OncoTargets and therapy, 9965-9973, 2019 | 4 | 2019 |
| Oncotype DX RS correlation with clinicopathologic risk factors and chemotherapy. Retrospective study in early stage ER positive breast cancer F Salih, F Calaud, K Rasul, M Elmistiri, N Elhadi, H Gazouani, ... Ann Breast Cancer 1, 1005, 2018 | 4 | 2018 |
| Rare case of norethisterone‐induced hepatitis: A case report EA Arafa, V Dhayabaran, NE Omar, A Awaisu Clinical Case Reports 10 (4), e05687, 2022 | 3 | 2022 |
| The flip of the coin of personalized cancer immunotherapy: a focused review on rare immune checkpoint related adverse effects NE Omar, HM Afifi, AO Sahal, R Mekkawi, H Elewa Immune Checkpoint Inhibitors-New Insights and Recent Progress, 2022 | 2 | 2022 |
| Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent … A Kanbour, F Salih, W Abualainin, M Abdelrazek, L Szabados, I Al-Bozom, ... OncoTargets and therapy, 659-667, 2022 | 2 | 2022 |
| Long-term moderate to severe complications of COVID-19 infection since 2019 to date: A protocol for systematic review and/or meta-analysis F Ata, P Iqbal, H Choudry, B Muthanna, HW Younas, OSA Tabar, K Fadah, ... Medicine: Case Reports and Study Protocols 2 (11), e0159, 2021 | 2 | 2021 |
| Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: a protocol for systematic review and meta-analysis N Kassem, AA Ghazy, M Abu-Tineh, NE Omar, AJ Nashwan, P Chandra, ... Medicine 99 (51), e23632, 2020 | 2 | 2020 |
| CLO19-045: Safety of immune checkpoint inhibitors in cancer patients with microsatellite instability-high (MSI-H) status: An experience from Qatar NEH Omar, S Nasser, M Gasim, M Khanna, AJ Nashwan, ... Journal of the National Comprehensive Cancer Network 17 (3.5), CLO19-045 …, 2019 | 2 | 2019 |
| Cutoff point for standard tube agglutination test in the diagnosis of human brucellosis in Egypt S Zaky, M Azab, RH Mansour, EA El-Moselhy, AM Bersy, NH Omar, ... Journal of Advanced Research 16, 162-163, 2019 | 2 | 2019 |
Prof.Mohamed A . Yassin,MDProfessor of Hematology ,Head of Hematology ,Hamad Medical Corporation,CMED QU在 hamad.qa 的电子邮件经过验证
